6.5 C
New York
Monday, December 6, 2021

This drug cocktail may help cure COVID-19 – says study

Must Read

Bob Dole: Former Republican senator died ‘early this morning in his sleep’

Bob Dole, who overcame severe World War II combat wounds to have a long political career that...

Study finds several new mutations that may evade natural and vaccine-acquired immunity

A new study has identified several possible mutations that could allow the virus to escape immune defenses, including natural...

First COVID infection or vaccine decides future immune responses

Instead of a one-size-fits-all strategy, researchers propose that developers customize vaccines based on a person's infection history.
Jiya Saini
Jiya Saini is a Journalist and Writer at Revyuh.com. She has been working with us since January 2018. After studying at Jamia Millia University, she is fascinated by smart lifestyle and smart living. She covers technology, games, sports and smart living, as well as good experience in press relations. She is also a freelance trainer for macOS and iOS, and In the past, she has worked with various online news magazines in India and Singapore. Email: jiya (at) revyuh (dot) com

COVID-19 is still claiming lives and infecting millions of more people around the world.

Although various vaccines have recently become available, making major gains toward avoiding COVID-19, what about individuals who are already infected?

Vaccines are not 100 percent effective, emphasizing the need for powerful antiviral medicines today more than ever.

Furthermore, some patients are unable to recieve vaccines due to medical reasons, and new types of SARS-CoV-2, the virus that causes COVID-19, that can breach vaccine-conferred immunity are being identified, indicating that we must look beyond prevention.

In a recent work published in iScience, scientists revealed a new drug combo that may help cure COVID-19 together.

The researchers began by establishing an experimental approach for screening treatments that may benefit from infection control.

This system used a type of cells called VeroE6/TMPRSS2 cells, which were manipulated to efficiently be infected with and produce SARS-CoV-2.

The researchers utilized this experimental approach to examine a panel of medicines previously permitted for clinical use, including remdesivir and chloroquine, which have been approved or are currently being studied as COVID-19 therapies.

They discovered two compounds that effectively suppressed SARS-CoV-2 infection: cepharanthine, which is used to treat inflammation, and nelfinavir, which is authorised to treat HIV infection.

Cepharanthine prevented the virus from entering cells by inhibiting its binding to a protein on the cell membrane that the virus uses as a gateway.

By contrast, nelfinavir inhibited the virus’s replication within the cell by blocking a protein required for replication.

Given the unique antiviral properties of these medicines, combining them may be extremely beneficial for patients.

Computational models show that a combination of cepharanthine and nelfinavir medication can accelerate the elimination of SARS-CoV-2 from the lungs of a patient by as little as 4.9 days.

These findings justify additional study into the therapeutic potential of cepharanthine/nelfinavir therapy; only then can we be certain that it is good and useful.

The researchers expect that by developing cepharanthine/nelfinavir therapy, they would be able to give doctors and patients a much-needed new treatment alternative.

Image Credit: Getty

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -